Research on CBD for Epilepsy

 

1. Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid.
Kozela E, Juknat A, Vogel Z.
Int J Mol Sci. 2017 Jul 31;18(8). pii: E1669. doi: 10.3390/ijms18081669. Review.
PMID: 28788104 [PubMed – in process]
Similar articles

 

2. Interactions between cannabidiol and commonly used antiepileptic drugs.
Gaston TE, Bebin EM, Cutter GR, Liu Y, Szaflarski JP; UAB CBD Program.
Epilepsia. 2017 Aug 6. doi: 10.1111/epi.13852. [Epub ahead of print]
PMID: 28782097 [PubMed – as supplied by publisher]
Similar articles

 

3. Could Cannabidiol be a Treatment Option for Intractable Childhood and Adolescent Epilepsy?
Koo CM, Kang HC.
J Epilepsy Res. 2017 Jun 30;7(1):16-20. doi: 10.14581/jer.17003. eCollection 2017 Jun. Review.
PMID: 28775950 [PubMed] Free PMC Article
Similar articles

 

4. Fewer Seizures With Cannabidiol in Catastrophic Epilepsy.
Slomski A.
JAMA. 2017 Jul 25;318(4):323. doi: 10.1001/jama.2017.8846. No abstract available.
PMID: 28742905 [PubMed – in process]
Similar articles

 

5. Effects of antiepileptic drugs on mitochondrial functions, morphology, kinetics, biogenesis, and survival.
Finsterer J, Scorza FA.
Epilepsy Res. 2017 Jul 13;136:5-11. doi: 10.1016/j.eplepsyres.2017.07.003. [Epub ahead of print] Review.
PMID: 28732239 [PubMed – as supplied by publisher]
Similar articles

 

6. Cannabinoids in Pediatrics.
Campbell CT, Phillips MS, Manasco K.
J Pediatr Pharmacol Ther. 2017 May-Jun;22(3):176-185. doi: 10.5863/1551-6776-22.3.176. Review.
PMID: 28638299 [PubMed – in process] Free PMC Article
Similar articles

 

7. Assessing the role of serotonergic receptors in cannabidiol’s anticonvulsant efficacy.
Pelz MC, Schoolcraft KD, Larson C, Spring MG, López HH.
Epilepsy Behav. 2017 Aug;73:111-118. doi: 10.1016/j.yebeh.2017.04.045. Epub 2017 Jun 16.
PMID: 28624721 [PubMed – in process]
Similar articles

 

8. Epilepsy: Cannabidiol reduces seizure frequency in Dravet syndrome.
Ridler C.
Nat Rev Neurol. 2017 Jul;13(7):383. doi: 10.1038/nrneurol.2017.86. Epub 2017 Jun 9. No abstract available.
PMID: 28621765 [PubMed – in process]
Similar articles

 

9. Quality of Life in Childhood Epilepsy in pediatric patients enrolled in a prospective, open-label clinical study with cannabidiol.
Rosenberg EC, Louik J, Conway E, Devinsky O, Friedman D.
Epilepsia. 2017 Jun 15. doi: 10.1111/epi.13815. [Epub ahead of print]
PMID: 28617940 [PubMed – as supplied by publisher]
Similar articles

 

10. Cannabis and intractable chronic pain: an explorative retrospective analysis of Italian cohort of 614 patients.
Fanelli G, De Carolis G, Leonardi C, Longobardi A, Sarli E, Allegri M, Schatman ME.
J Pain Res. 2017 May 22;10:1217-1224. doi: 10.2147/JPR.S132814. eCollection 2017.
PMID: 28579820 [PubMed – in process] Free PMC Article
Similar articles

 

11. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA, Wright S; Cannabidiol in Dravet Syndrome Study Group.
N Engl J Med. 2017 May 25;376(21):2011-2020. doi: 10.1056/NEJMoa1611618.
PMID: 28538134 [PubMed – indexed for MEDLINE]
Similar articles

 

12. Cannabidiol in Patients With Intractable Epilepsy Due to TSC: A Possible Medication But Not a Miracle.
Nickels K.
Epilepsy Curr. 2017 Mar-Apr;17(2):91-92. doi: 10.5698/1535-7511.17.2.91. No abstract available.
PMID: 28490996 [PubMed – in process] Free PMC Article
Similar articles

 

13. Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).
Klein BD, Jacobson CA, Metcalf CS, Smith MD, Wilcox KS, Hampson AJ, Kehne JH.
Neurochem Res. 2017 Jul;42(7):1939-1948. doi: 10.1007/s11064-017-2287-8. Epub 2017 May 6.
PMID: 28478594 [PubMed – in process]
Similar articles

 

14. Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions.
Ostendorf AP, Ng YT.
Neuropsychiatr Dis Treat. 2017 Apr 20;13:1131-1140. doi: 10.2147/NDT.S115996. eCollection 2017. Review.
PMID: 28461749 [PubMed – in process] Free PMC Article
Similar articles

 

15. Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome after Human Papillomavirus Vaccination.
Palmieri B, Laurino C, Vadalà M.
Isr Med Assoc J. 2017 Feb;19(2):79-84.
PMID: 28457055 [PubMed – in process] Free Article
Similar articles

 

16. Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome.
Kaplan EH, Offermann EA, Sievers JW, Comi AM.
Pediatr Neurol. 2017 Jun;71:18-23.e2. doi: 10.1016/j.pediatrneurol.2017.02.009. Epub 2017 Feb 22.
PMID: 28454984 [PubMed – in process]
Similar articles

 

17. Neurological aspects of medical use of cannabidiol.
Mannucci C, Navarra M, Calapai F, Spagnolo EV, Busardò FP, Da Cas R, Ippolito FM, Calapai G.
CNS Neurol Disord Drug Targets. 2017 Apr 13. doi: 10.2174/1871527316666170413114210. [Epub ahead of print]
PMID: 28412918 [PubMed – as supplied by publisher]
Similar articles

 

18. Report from a Survey of Parents Regarding the Use of Cannabidiol <i>(Medicinal cannabis)</i> in Mexican Children with Refractory Epilepsy.
Aguirre-Velázquez CG.
Neurol Res Int. 2017;2017:2985729. doi: 10.1155/2017/2985729. Epub 2017 Mar 14.
PMID: 28392943 [PubMed – in process] Free PMC Article
Similar articles

 

19. Cannabinoids as hippocampal network administrators.
Lupica CR, Hu Y, Devinsky O, Hoffman AF.
Neuropharmacology. 2017 Sep 15;124:25-37. doi: 10.1016/j.neuropharm.2017.04.003. Epub 2017 Apr 6. Review.
PMID: 28392266 [PubMed – in process]
Similar articles

 

20. Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy.
Do Val-da Silva RA, Peixoto-Santos JE, Kandratavicius L, De Ross JB, Esteves I, De Martinis BS, Alves MN, Scandiuzzi RC, Hallak JE, Zuardi AW, Crippa JA, Leite JP.
Front Pharmacol. 2017 Mar 17;8:131. doi: 10.3389/fphar.2017.00131. eCollection 2017.
PMID: 28367124 [PubMed – in process] Free PMC Article
Similar articles

 

21. Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?
Maccarrone M, Maldonado R, Casas M, Henze T, Centonze D.
Expert Rev Clin Pharmacol. 2017 Apr;10(4):443-455. doi: 10.1080/17512433.2017.1292849. Epub 2017 Feb 28. Review.
PMID: 28276775 [PubMed – indexed for MEDLINE]
Similar articles

 

22. The current status of artisanal cannabis for the treatment of epilepsy in the United States.
Sulak D, Saneto R, Goldstein B.
Epilepsy Behav. 2017 May;70(Pt B):328-333. doi: 10.1016/j.yebeh.2016.12.032. Epub 2017 Feb 21.
PMID: 28254350 [PubMed – in process]
Similar articles

 

23. Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy.
Szaflarski M, Hansen B, Bebin EM, Szaflarski JP.
Epilepsy Behav. 2017 May;70(Pt B):364-369. doi: 10.1016/j.yebeh.2016.12.033. Epub 2017 Feb 21.
PMID: 28236578 [PubMed – in process]
Similar articles

 

24. Cannabis cultivation: Methodological issues for obtaining medical-grade product.
Chandra S, Lata H, ElSohly MA, Walker LA, Potter D.
Epilepsy Behav. 2017 May;70(Pt B):302-312. doi: 10.1016/j.yebeh.2016.11.029. Epub 2017 Feb 13. Review.
PMID: 28202406 [PubMed – in process]
Similar articles

 

25. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC, Patra PH, Whalley BJ.
Epilepsy Behav. 2017 May;70(Pt B):319-327. doi: 10.1016/j.yebeh.2016.11.006. Epub 2017 Feb 9. Review.
PMID: 28190698 [PubMed – in process]
Similar articles

 

26. Treatment issues for children with epilepsy transitioning to adult care.
Nabbout R, Camfield CS, Andrade DM, Arzimanoglou A, Chiron C, Cramer JA, French JA, Kossoff E, Mula M, Camfield PR.
Epilepsy Behav. 2017 Apr;69:153-160. doi: 10.1016/j.yebeh.2016.11.008. Epub 2017 Feb 8. Review.
PMID: 28188045 [PubMed – in process]
Similar articles

 

27. Cannabinoids in treatment-resistant epilepsy: A review.
O’Connell BK, Gloss D, Devinsky O.
Epilepsy Behav. 2017 May;70(Pt B):341-348. doi: 10.1016/j.yebeh.2016.11.012. Epub 2017 Feb 8. Review.
PMID: 28188044 [PubMed – in process]
Similar articles

 

28. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
Mead A.
Epilepsy Behav. 2017 May;70(Pt B):288-291. doi: 10.1016/j.yebeh.2016.11.021. Epub 2017 Feb 4. Review.
PMID: 28169144 [PubMed – in process] Free Article
Similar articles

 

29. Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII).
Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS.
Epilepsia. 2017 Feb;58(2):181-221. doi: 10.1111/epi.13634. Epub 2017 Jan 23. Review.
PMID: 28111749 [PubMed – indexed for MEDLINE]
Similar articles

 

30. Neuroimaging studies towards understanding the central effects of pharmacological cannabis products on patients with epilepsy.
Allendorfer JB, Szaflarski JP.
Epilepsy Behav. 2017 May;70(Pt B):349-354. doi: 10.1016/j.yebeh.2016.11.020. Epub 2017 Jan 18. Review.
PMID: 28109780 [PubMed – in process]
Similar articles

 

31. Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s.
Friedman D, Sirven JI.
Epilepsy Behav. 2017 May;70(Pt B):298-301. doi: 10.1016/j.yebeh.2016.11.033. Epub 2017 Jan 12. Review.
PMID: 28089286 [PubMed – in process]
Similar articles

 

32. Cannabidiol Claims and Misconceptions.
Russo EB.
Trends Pharmacol Sci. 2017 Mar;38(3):198-201. doi: 10.1016/j.tips.2016.12.004. Epub 2017 Jan 12. Erratum in: Trends Pharmacol Sci. 2017 May;38(5):499.
PMID: 28089139 [PubMed – in process]
Similar articles

 

33. Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers.
Babalonis S, Haney M, Malcolm RJ, Lofwall MR, Votaw VR, Sparenborg S, Walsh SL.
Drug Alcohol Depend. 2017 Mar 1;172:9-13. doi: 10.1016/j.drugalcdep.2016.11.030. Epub 2016 Dec 14.
PMID: 28088032 [PubMed – in process]
Similar articles

 

34. Pharmacology of cannabinoids in the treatment of epilepsy.
Gaston TE, Friedman D.
Epilepsy Behav. 2017 May;70(Pt B):313-318. doi: 10.1016/j.yebeh.2016.11.016. Epub 2017 Jan 10. Review.
PMID: 28087250 [PubMed – in process]
Similar articles

 

35. Cannabis and epilepsy: An ancient treatment returns to the fore.
Russo EB.
Epilepsy Behav. 2017 May;70(Pt B):292-297. doi: 10.1016/j.yebeh.2016.09.040. Epub 2016 Dec 15. Review.
PMID: 27989385 [PubMed – in process]
Similar articles

 

36. Duration of use of oral cannabis extract in a cohort of pediatric epilepsy patients.
Treat L, Chapman KE, Colborn KL, Knupp KG.
Epilepsia. 2017 Jan;58(1):123-127. doi: 10.1111/epi.13617. Epub 2016 Nov 18.
PMID: 27859038 [PubMed – indexed for MEDLINE]
Similar articles

 

37. Cannabidiol Mellows Out Resurgent Sodium Current.
Thompson CH, Kearney JA.
Epilepsy Curr. 2016 Nov-Dec;16(6):399-401. No abstract available.
PMID: 27857623 [PubMed – in process] Free PMC Article
Similar articles

 

38. Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function.
Gruber SA, Sagar KA, Dahlgren MK, Racine MT, Smith RT, Lukas SE.
Front Pharmacol. 2016 Oct 13;7:355. eCollection 2016.
PMID: 27790138 [PubMed – in process] Free PMC Article
Similar articles

 

39. Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol.
Crippa JA, Crippa AC, Hallak JE, Martín-Santos R, Zuardi AW.
Front Pharmacol. 2016 Sep 30;7:359. eCollection 2016.
PMID: 27746737 [PubMed – in process] Free PMC Article
Similar articles

 

40. Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.
Hess EJ, Moody KA, Geffrey AL, Pollack SF, Skirvin LA, Bruno PL, Paolini JL, Thiele EA.
Epilepsia. 2016 Oct;57(10):1617-1624. doi: 10.1111/epi.13499. Epub 2016 Oct 3.
PMID: 27696387 [PubMed – indexed for MEDLINE]
Similar articles

 

41. Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.
Gofshteyn JS, Wilfong A, Devinsky O, Bluvstein J, Charuta J, Ciliberto MA, Laux L, Marsh ED.
J Child Neurol. 2017 Jan;32(1):35-40. doi: 10.1177/0883073816669450. Epub 2016 Sep 29.
PMID: 27655472 [PubMed – in process]
Similar articles

 

42. Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes.
Peace MR, Butler KE, Wolf CE, Poklis JL, Poklis A.
Front Pharmacol. 2016 Aug 29;7:279. doi: 10.3389/fphar.2016.00279. eCollection 2016.
PMID: 27621706 [PubMed] Free PMC Article
Similar articles

 

43. From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?
Lippiello P, Balestrini S, Leo A, Coppola A, Citraro R, Elia M, Russo E, De Sarro G.
Curr Pharm Des. 2016;22(42):6426-6433. doi: 10.2174/1381612822666160831122722.
PMID: 27587196 [PubMed – in process]
Similar articles

 

44. Cannabidiol and Epilepsy: Sifting, Winnowing and Buzz.
Gidal BE.
Epilepsy Curr. 2016 Jul-Aug;16(4):239-41. doi: 10.5698/1535-7511-16.4.239. No abstract available.
PMID: 27582660 [PubMed] Free PMC Article
Similar articles

 

45. Emerging Antiepileptic Drugs for Severe Pediatric Epilepsies.
Mudigoudar B, Weatherspoon S, Wheless JW.
Semin Pediatr Neurol. 2016 May;23(2):167-79. doi: 10.1016/j.spen.2016.06.003. Epub 2016 Jun 4.
PMID: 27544474 [PubMed – in process]
Similar articles

 

46. The Utility of Cannabidiol in the Treatment of Refractory Epilepsy.
Reddy DS.
Clin Pharmacol Ther. 2017 Feb;101(2):182-184. doi: 10.1002/cpt.441. Epub 2016 Sep 29. Review.
PMID: 27506704 [PubMed – indexed for MEDLINE]
Similar articles

 

47. Medical Marijuana for Epilepsy?
Kolikonda MK, Srinivasan K, Enja M, Sagi V, Lippmann S.
Innov Clin Neurosci. 2016 Apr 1;13(3-4):23-6. eCollection 2016 Mar-Apr.
PMID: 27354925 [PubMed] Free PMC Article
Similar articles

 

48. Cannabidiol in patients with treatment-resistant epilepsy – Authors’ reply.
Devinsky O, Marsh E, Friedman D.
Lancet Neurol. 2016 May;15(6):545-6. doi: 10.1016/S1474-4422(16)00120-4. Epub 2016 Apr 11. No abstract available.
PMID: 27302119 [PubMed – in process]
Similar articles

 

49. Cannabidiol in patients with treatment-resistant epilepsy.
Bauer PR, Sander JW.
Lancet Neurol. 2016 May;15(6):544. doi: 10.1016/S1474-4422(16)00118-6. Epub 2016 Apr 11. No abstract available.
PMID: 27302118 [PubMed – in process]
Similar articles

 

50. Cannabidiol in patients with treatment-resistant epilepsy.
Mandelbaum DE.
Lancet Neurol. 2016 May;15(6):544-5. doi: 10.1016/S1474-4422(16)00122-8. Epub 2016 Apr 11. No abstract available.
PMID: 27302117 [PubMed – in process]
Similar articles

 

51. Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol.
Patel RR, Barbosa C, Brustovetsky T, Brustovetsky N, Cummins TR.
Brain. 2016 Aug;139(Pt 8):2164-81. doi: 10.1093/brain/aww129. Epub 2016 Jun 5.
PMID: 27267376 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

52. Treatment of Dravet Syndrome.
Wirrell EC.
Can J Neurol Sci. 2016 Jun;43 Suppl 3:S13-8. doi: 10.1017/cjn.2016.249. Review.
PMID: 27264138 [PubMed – indexed for MEDLINE]
Similar articles

 

53. ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice.
Brzozowska N, Li KM, Wang XS, Booth J, Stuart J, McGregor IS, Arnold JC.
PeerJ. 2016 May 26;4:e2081. doi: 10.7717/peerj.2081. eCollection 2016.
PMID: 27257556 [PubMed] Free PMC Article
Similar articles

 

54. Targeted Treatment in Childhood Epilepsy Syndromes.
Vezyroglou K, Cross JH.
Curr Treat Options Neurol. 2016 Jun;18(6):29. doi: 10.1007/s11940-016-0407-4. Review.
PMID: 27154366 [PubMed] Free PMC Article
Similar articles

 

55. Pediatric Concerns Due to Expanded Cannabis Use: Unintended Consequences of Legalization.
Wang GS.
J Med Toxicol. 2017 Mar;13(1):99-105. doi: 10.1007/s13181-016-0552-x. Epub 2016 May 2.
PMID: 27139708 [PubMed – in process]
Similar articles

 

56. Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R, Ambwani SR, Singh S.
Curr Clin Pharmacol. 2016;11(2):110-7. Review.
PMID: 27086601 [PubMed – in process]
Similar articles

 

57. Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome.
Rubio M, Valdeolivas S, Piscitelli F, Verde R, Satta V, Barroso E, Montolio M, Aras LM, Di Marzo V, Sagredo O, Fernández-Ruiz J.
Pharmacol Res Perspect. 2016 Mar 5;4(2):e00220. doi: 10.1002/prp2.220. eCollection 2016 Apr.
PMID: 27069631 [PubMed] Free PMC Article
Similar articles

 

58. Cannabidiol and epilepsy: Rationale and therapeutic potential.
Leo A, Russo E, Elia M.
Pharmacol Res. 2016 May;107:85-92. doi: 10.1016/j.phrs.2016.03.005. Epub 2016 Mar 11. Review.
PMID: 26976797 [PubMed – indexed for MEDLINE]
Similar articles

 

59. Orrin Devinsky: breaking through treatment-resistant epilepsy.
Kirby T.
Lancet Neurol. 2016 Mar;15(3):244. doi: 10.1016/S1474-4422(16)00028-4. Epub 2016 Feb 10. No abstract available.
PMID: 26888351 [PubMed – indexed for MEDLINE]
Similar articles

 

60. Cannabinoids for pediatric epilepsy? Up in smoke or real science?
Filloux FM.
Transl Pediatr. 2015 Oct;4(4):271-82. doi: 10.3978/j.issn.2224-4336.2015.10.03. Review.
PMID: 26835389 [PubMed] Free PMC Article
Similar articles

 

61. Cannabidiol oil in the treatment of super refractory status epilepticus. A case report.
Rosemergy I, Adler J, Psirides A.
Seizure. 2016 Feb;35:56-8. doi: 10.1016/j.seizure.2016.01.009. Epub 2016 Jan 11. No abstract available.
PMID: 26803051 [PubMed – indexed for MEDLINE] Free Article
Similar articles

 

62. CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience.
Tzadok M, Uliel-Siboni S, Linder I, Kramer U, Epstein O, Menascu S, Nissenkorn A, Yosef OB, Hyman E, Granot D, Dor M, Lerman-Sagie T, Ben-Zeev B.
Seizure. 2016 Feb;35:41-4. doi: 10.1016/j.seizure.2016.01.004. Epub 2016 Jan 6.
PMID: 26800377 [PubMed – indexed for MEDLINE] Free Article
Similar articles

 

63. The Pharmacological Basis of Cannabis Therapy for Epilepsy.
Reddy DS, Golub VM.
J Pharmacol Exp Ther. 2016 Apr;357(1):45-55. doi: 10.1124/jpet.115.230151. Epub 2016 Jan 19. Review.
PMID: 26787773 [PubMed – indexed for MEDLINE] Free Article
Similar articles

 

64. Cannabidiol for epilepsy: trying to see through the haze.
Detyniecki K, Hirsch LJ.
Lancet Neurol. 2016 Mar;15(3):235-7. doi: 10.1016/S1474-4422(16)00002-8. Epub 2016 Jan 9. No abstract available.
PMID: 26776916 [PubMed – indexed for MEDLINE]
Similar articles

 

65. Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation.
Lee WS, Erdelyi K, Matyas C, Mukhopadhyay P, Varga ZV, Liaudet L, Haskó G, Čiháková D, Mechoulam R, Pacher P.
Mol Med. 2016 Jan 8. doi: 10.2119/molmed.2016.00007. [Epub ahead of print]
PMID: 26772776 [PubMed – as supplied by publisher] Free PMC Article
Similar articles

 

66. Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure.
Hosseinzadeh M, Nikseresht S, Khodagholi F, Naderi N, Maghsoudi N.
J Mol Neurosci. 2016 Apr;58(4):432-40. doi: 10.1007/s12031-015-0703-6. Epub 2016 Jan 6.
PMID: 26738731 [PubMed – indexed for MEDLINE]
Similar articles

 

67. Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
Devinsky O, Marsh E, Friedman D, Thiele E, Laux L, Sullivan J, Miller I, Flamini R, Wilfong A, Filloux F, Wong M, Tilton N, Bruno P, Bluvstein J, Hedlund J, Kamens R, Maclean J, Nangia S, Singhal NS, Wilson CA, Patel A, Cilio MR.
Lancet Neurol. 2016 Mar;15(3):270-8. doi: 10.1016/S1474-4422(15)00379-8. Epub 2015 Dec 24. Erratum in: Lancet Neurol. 2016 Apr;15(4):352.
PMID: 26724101 [PubMed – indexed for MEDLINE]
Similar articles  1 comment

 

68. Cannabidiol as potential treatment in refractory pediatric epilepsy.
Paolino MC, Ferretti A, Papetti L, Villa MP, Parisi P.
Expert Rev Neurother. 2016;16(1):17-21. doi: 10.1586/14737175.2016.1121098. Epub 2015 Dec 9.
PMID: 26567560 [PubMed – in process]
Similar articles

 

69. Investigational new drugs for focal epilepsy.
Mula M.
Expert Opin Investig Drugs. 2016;25(1):1-5. doi: 10.1517/13543784.2016.1110144. Epub 2015 Nov 4.
PMID: 26535466 [PubMed – indexed for MEDLINE]
Similar articles

 

70. Polypharmacology Shakes Hands with Complex Aetiopathology.
Brodie JS, Di Marzo V, Guy GW.
Trends Pharmacol Sci. 2015 Dec;36(12):802-21. doi: 10.1016/j.tips.2015.08.010. Epub 2015 Oct 1.
PMID: 26434643 [PubMed – indexed for MEDLINE]
Similar articles

 

71. Cannabinoids, cannabinoid receptors and tinnitus.
Smith PF, Zheng Y.
Hear Res. 2016 Feb;332:210-6. doi: 10.1016/j.heares.2015.09.014. Epub 2015 Oct 1. Review.
PMID: 26433054 [PubMed – indexed for MEDLINE]
Similar articles

 

72. Cannabis and Endocannabinoid Signaling in Epilepsy.
Katona I.
Handb Exp Pharmacol. 2015;231:285-316. doi: 10.1007/978-3-319-20825-1_10. Review.
PMID: 26408165 [PubMed – indexed for MEDLINE]
Similar articles

 

73. Drug development: The treasure chest.
Owens B.
Nature. 2015 Sep 24;525(7570):S6-8. doi: 10.1038/525S6a. No abstract available.
PMID: 26398738 [PubMed – indexed for MEDLINE]
Similar articles

 

74. Cannabinoids in the Treatment of Epilepsy.
Friedman D, Devinsky O.
N Engl J Med. 2015 Sep 10;373(11):1048-58. doi: 10.1056/NEJMra1407304. Review. No abstract available.
PMID: 26352816 [PubMed – indexed for MEDLINE]
Similar articles

 

75. Altering Rules on Cannabidiol Therapies.
Toth Z.
State Legis. 2015 Sep;41(8):11. No abstract available.
PMID: 26320274 [PubMed – indexed for MEDLINE]
Similar articles

 

76. High dosage of cannabidiol (CBD) alleviates pentylenetetrazole-induced epilepsy in rats by exerting an anticonvulsive effect.
Mao K, You C, Lei D, Zhang H.
Int J Clin Exp Med. 2015 Jun 15;8(6):8820-7. eCollection 2015.
PMID: 26309534 [PubMed] Free PMC Article
Similar articles

 

77. Marijuana Use in Epilepsy: The Myth and the Reality.
Detyniecki K, Hirsch L.
Curr Neurol Neurosci Rep. 2015 Oct;15(10):65. doi: 10.1007/s11910-015-0586-5. Review.
PMID: 26299273 [PubMed – indexed for MEDLINE]
Similar articles

 

78. Cannabidiol, a Cannabis sativa constituent, inhibits cocaine-induced seizures in mice: Possible role of the mTOR pathway and reduction in glutamate release.
Gobira PH, Vilela LR, Gonçalves BD, Santos RP, de Oliveira AC, Vieira LB, Aguiar DC, Crippa JA, Moreira FA.
Neurotoxicology. 2015 Sep;50:116-21. doi: 10.1016/j.neuro.2015.08.007. Epub 2015 Aug 15.
PMID: 26283212 [PubMed – indexed for MEDLINE]
Similar articles

 

79. Cannabinoids and Epilepsy.
Rosenberg EC, Tsien RW, Whalley BJ, Devinsky O.
Neurotherapeutics. 2015 Oct;12(4):747-68. doi: 10.1007/s13311-015-0375-5. Review.
PMID: 26282273 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

80. Cannabinoids: is there a potential treatment role in epilepsy?
Blair RE, Deshpande LS, DeLorenzo RJ.
Expert Opin Pharmacother. 2015;16(13):1911-4. Epub 2015 Aug 3.
PMID: 26234319 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

81. Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy.
Geffrey AL, Pollack SF, Bruno PL, Thiele EA.
Epilepsia. 2015 Aug;56(8):1246-51. doi: 10.1111/epi.13060. Epub 2015 Jun 26.
PMID: 26114620 [PubMed – indexed for MEDLINE] Free Article
Similar articles

 

82. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation.
Stanley CP, Hind WH, Tufarelli C, O’Sullivan SE.
Cardiovasc Res. 2015 Sep 1;107(4):568-78. doi: 10.1093/cvr/cvv179. Epub 2015 Jun 19.
PMID: 26092099 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

83. Cannabidiol rescues acute hepatic toxicity and seizure induced by cocaine.
Vilela LR, Gomides LF, David BA, Antunes MM, Diniz AB, Moreira Fde A, Menezes GB.
Mediators Inflamm. 2015;2015:523418. doi: 10.1155/2015/523418. Epub 2015 Apr 27.
PMID: 25999668 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

84. [Cannabinoids in neurology–Brazilian Academy of Neurology].
Brucki SM, Frota NA, Schestatsky P, Souza AH, Carvalho VN, Manreza ML, Mendes MF, Comini-Frota E, Vasconcelos C, Tumas V, Ferraz HB, Barbosa E, Jurno ME.
Arq Neuropsiquiatr. 2015 Apr;73(4):371-4. doi: 10.1590/0004-282X20150041. Epub 2015 Apr 1. Portuguese.
PMID: 25992535 [PubMed – indexed for MEDLINE] Free Article
Similar articles

 

85. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
Hussain SA, Zhou R, Jacobson C, Weng J, Cheng E, Lay J, Hung P, Lerner JT, Sankar R.
Epilepsy Behav. 2015 Jun;47:138-41. doi: 10.1016/j.yebeh.2015.04.009. Epub 2015 Apr 29.
PMID: 25935511 [PubMed – indexed for MEDLINE]
Similar articles

 

86. Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report.
Saade D, Joshi C.
Pediatr Neurol. 2015 May;52(5):544-7. doi: 10.1016/j.pediatrneurol.2015.02.008. Epub 2015 Feb 19.
PMID: 25882081 [PubMed – indexed for MEDLINE]
Similar articles

 

87. Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy.
Press CA, Knupp KG, Chapman KE.
Epilepsy Behav. 2015 Apr;45:49-52. doi: 10.1016/j.yebeh.2015.02.043. Epub 2015 Apr 3.
PMID: 25845492 [PubMed – indexed for MEDLINE]
Similar articles

 

88. Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII).
Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS.
Epilepsy Res. 2015 Mar;111:85-141. doi: 10.1016/j.eplepsyres.2015.01.001. Epub 2015 Jan 19. Review.
PMID: 25769377 [PubMed – indexed for MEDLINE]
Similar articles

 

89. Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
Elmes MW, Kaczocha M, Berger WT, Leung K, Ralph BP, Wang L, Sweeney JM, Miyauchi JT, Tsirka SE, Ojima I, Deutsch DG.
J Biol Chem. 2015 Apr 3;290(14):8711-21. doi: 10.1074/jbc.M114.618447. Epub 2015 Feb 9.
PMID: 25666611 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

90. Phytocannabinoids and epilepsy.
dos Santos RG, Hallak JE, Leite JP, Zuardi AW, Crippa JA.
J Clin Pharm Ther. 2015 Apr;40(2):135-43. doi: 10.1111/jcpt.12235. Epub 2014 Dec 4. Review.
PMID: 25475762 [PubMed – indexed for MEDLINE]
Similar articles

 

91. Medical marijuana in neurology.
Benbadis SR, Sanchez-Ramos J, Bozorg A, Giarratano M, Kalidas K, Katzin L, Robertson D, Vu T, Smith A, Zesiewicz T.
Expert Rev Neurother. 2014 Dec;14(12):1453-65. doi: 10.1586/14737175.2014.985209. Review.
PMID: 25427150 [PubMed – indexed for MEDLINE]
Similar articles

 

92. Commentary: medical marijuana survey &amp; epilepsy.
Devinsky O.
Epilepsia. 2015 Jan;56(1):7-8. doi: 10.1111/epi.12853. Epub 2014 Nov 20. No abstract available.
PMID: 25413243 [PubMed – indexed for MEDLINE] Free Article
Similar articles

 

93. Fewer specialists support using medical marijuana and CBD in treating epilepsy patients compared with other medical professionals and patients: result of Epilepsia’s survey.
Mathern GW, Beninsig L, Nehlig A.
Epilepsia. 2015 Jan;56(1):1-6. doi: 10.1111/epi.12843. Epub 2014 Nov 20.
PMID: 25413126 [PubMed – indexed for MEDLINE] Free Article
Similar articles

 

94. Cannabidiol: promise and pitfalls.
Welty TE, Luebke A, Gidal BE.
Epilepsy Curr. 2014 Sep;14(5):250-2. doi: 10.5698/1535-7597-14.5.250.
PMID: 25346628 [PubMed] Free PMC Article
Similar articles

 

95. Cannabis, cannabidiol, and epilepsy–from receptors to clinical response.
Szaflarski JP, Bebin EM.
Epilepsy Behav. 2014 Dec;41:277-82. doi: 10.1016/j.yebeh.2014.08.135. Epub 2014 Oct 1. Review.
PMID: 25282526 [PubMed – indexed for MEDLINE]
Similar articles

 

96. Cannabis, cannabidiol, and epilepsies: the truth is somewhere in the middle.
Sirven JI.
Epilepsy Behav. 2014 Dec;41:270-1. doi: 10.1016/j.yebeh.2014.09.006. Epub 2014 Sep 22. No abstract available.
PMID: 25248668 [PubMed – indexed for MEDLINE]
Similar articles

 

97. Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability.
Iannotti FA, Hill CL, Leo A, Alhusaini A, Soubrane C, Mazzarella E, Russo E, Whalley BJ, Di Marzo V, Stephens GJ.
ACS Chem Neurosci. 2014 Nov 19;5(11):1131-41. doi: 10.1021/cn5000524. Epub 2014 Jul 29.
PMID: 25029033 [PubMed – indexed for MEDLINE]
Similar articles

 

98. Cannabidiol and medical marijuana for the treatment of epilepsy.
Mathern G, Nehlig A, Sperling M.
Epilepsia. 2014 Jun;55(6):781-2. doi: 10.1111/epi.12647. Epub 2014 May 22. No abstract available.
PMID: 24854631 [PubMed – indexed for MEDLINE] Free Article
Similar articles

 

99. The case for assessing cannabidiol in epilepsy.
Cilio MR, Thiele EA, Devinsky O.
Epilepsia. 2014 Jun;55(6):787-90. doi: 10.1111/epi.12635. Epub 2014 May 22.
PMID: 24854434 [PubMed – indexed for MEDLINE] Free Article
Similar articles

 

100. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky O, Cilio MR, Cross H, Fernandez-Ruiz J, French J, Hill C, Katz R, Di Marzo V, Jutras-Aswad D, Notcutt WG, Martinez-Orgado J, Robson PJ, Rohrback BG, Thiele E, Whalley B, Friedman D.
Epilepsia. 2014 Jun;55(6):791-802. doi: 10.1111/epi.12631. Epub 2014 May 22. Review.
PMID: 24854329 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

101. The case for medical marijuana in epilepsy.
Maa E, Figi P.
Epilepsia. 2014 Jun;55(6):783-6. doi: 10.1111/epi.12610. Epub 2014 May 22.
PMID: 24854149 [PubMed – indexed for MEDLINE] Free Article
Similar articles

 

102. Pot ingredient for epilepsy.
Sneed A.
Sci Am. 2014 May;310(5):29. No abstract available.
PMID: 24783586 [PubMed – indexed for MEDLINE]
Similar articles

 

103. Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se.
Hill AJ, Jones NA, Smith I, Hill CL, Williams CM, Stephens GJ, Whalley BJ.
Neurosci Lett. 2014 Apr 30;566:269-74. doi: 10.1016/j.neulet.2014.03.013. Epub 2014 Mar 16.
PMID: 24642454 [PubMed – indexed for MEDLINE]
Similar articles

 

104. Cannabinoids for epilepsy.
Gloss D, Vickrey B.
Cochrane Database Syst Rev. 2014 Mar 5;(3):CD009270. doi: 10.1002/14651858.CD009270.pub3. Review.
PMID: 24595491 [PubMed – indexed for MEDLINE]
Similar articles

 

105. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.
Porter BE, Jacobson C.
Epilepsy Behav. 2013 Dec;29(3):574-7. doi: 10.1016/j.yebeh.2013.08.037.
PMID: 24237632 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

106. Therapeutic potential of cannabinoid medicines.
Robson PJ.
Drug Test Anal. 2014 Jan-Feb;6(1-2):24-30. doi: 10.1002/dta.1529. Epub 2013 Sep 4. Review.
PMID: 24006213 [PubMed – indexed for MEDLINE]
Similar articles

 

107. Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.
Hill TD, Cascio MG, Romano B, Duncan M, Pertwee RG, Williams CM, Whalley BJ, Hill AJ.
Br J Pharmacol. 2013 Oct;170(3):679-92. doi: 10.1111/bph.12321.
PMID: 23902406 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

108. The role of potassium BK channels in anticonvulsant effect of cannabidiol in pentylenetetrazole and maximal electroshock models of seizure in mice.
Shirazi-zand Z, Ahmad-Molaei L, Motamedi F, Naderi N.
Epilepsy Behav. 2013 Jul;28(1):1-7. doi: 10.1016/j.yebeh.2013.03.009. Epub 2013 May 3.
PMID: 23644464 [PubMed – indexed for MEDLINE]
Similar articles

 

109. Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses.
Sylantyev S, Jensen TP, Ross RA, Rusakov DA.
Proc Natl Acad Sci U S A. 2013 Mar 26;110(13):5193-8. doi: 10.1073/pnas.1211204110. Epub 2013 Mar 7.
PMID: 23472002 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

110. Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
Pertwee RG.
Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3353-63. doi: 10.1098/rstb.2011.0381. Review.
PMID: 23108552 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

111. Cannabinoids for epilepsy.
Gloss D, Vickrey B.
Cochrane Database Syst Rev. 2012 Jun 13;(6):CD009270. doi: 10.1002/14651858.CD009270.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;(3):CD009270.
PMID: 22696383 [PubMed – indexed for MEDLINE]
Similar articles

 

112. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J.
Br J Clin Pharmacol. 2013 Feb;75(2):323-33. doi: 10.1111/j.1365-2125.2012.04341.x. Review.
PMID: 22625422 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

113. Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.
Jones NA, Glyn SE, Akiyama S, Hill TD, Hill AJ, Weston SE, Burnett MD, Yamasaki Y, Stephens GJ, Whalley BJ, Williams CM.
Seizure. 2012 Jun;21(5):344-52. doi: 10.1016/j.seizure.2012.03.001. Epub 2012 Apr 19.
PMID: 22520455 [PubMed – indexed for MEDLINE] Free Article
Similar articles

 

114. Cannabidiol in humans-the quest for therapeutic targets.
Zhornitsky S, Potvin S.
Pharmaceuticals (Basel). 2012 May 21;5(5):529-52. doi: 10.3390/ph5050529.
PMID: 24281562 [PubMed] Free PMC Article
Similar articles

 

115. Phytocannabinoids as novel therapeutic agents in CNS disorders.
Hill AJ, Williams CM, Whalley BJ, Stephens GJ.
Pharmacol Ther. 2012 Jan;133(1):79-97. doi: 10.1016/j.pharmthera.2011.09.002. Epub 2011 Sep 6. Review.
PMID: 21924288 [PubMed – indexed for MEDLINE]
Similar articles

 

116. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo EB.
Br J Pharmacol. 2011 Aug;163(7):1344-64. doi: 10.1111/j.1476-5381.2011.01238.x. Review.
PMID: 21749363 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

117. Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.
Jones NA, Hill AJ, Smith I, Bevan SA, Williams CM, Whalley BJ, Stephens GJ.
J Pharmacol Exp Ther. 2010 Feb;332(2):569-77. doi: 10.1124/jpet.109.159145. Epub 2009 Nov 11.
PMID: 19906779 [PubMed – indexed for MEDLINE] Free PMC Article
Similar articles

 

118. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.
Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R.
Trends Pharmacol Sci. 2009 Oct;30(10):515-27. doi: 10.1016/j.tips.2009.07.006. Epub 2009 Sep 2. Review. Erratum in: Trends Pharmacol Sci. 2009 Dec;30(12):609.
PMID: 19729208 [PubMed – indexed for MEDLINE]
Similar articles

 

119. Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats.
Malone DT, Jongejan D, Taylor DA.
Pharmacol Biochem Behav. 2009 Aug;93(2):91-6. doi: 10.1016/j.pbb.2009.04.010. Epub 2009 Apr 23.
PMID: 19393686 [PubMed – indexed for MEDLINE]
Similar articles

 

120. Potential therapeutical effects of cannabidiol in children with pharmacoresistant epilepsy.
Cortesi M, Fusar-Poli P.
Med Hypotheses. 2007;68(4):920-1. Epub 2006 Nov 16. No abstract available.
PMID: 17112679 [PubMed – indexed for MEDLINE]
Similar articles

 

121. Medicinal cannabis: is delta9-tetrahydrocannabinol necessary for all its effects?
Wilkinson JD, Whalley BJ, Baker D, Pryce G, Constanti A, Gibbons S, Williamson EM.
J Pharm Pharmacol. 2003 Dec;55(12):1687-94.
PMID: 14738597 [PubMed – indexed for MEDLINE]
Similar articles

 

122. Neuroscience. Stout guards of the central nervous system.
Mechoulam R, Lichtman AH.
Science. 2003 Oct 3;302(5642):65-7.
PMID: 14526067 [PubMed – indexed for MEDLINE]
Similar articles

 

123. Cannabis-based medicines–GW pharmaceuticals: high CBD, high THC, medicinal cannabis–GW pharmaceuticals, THC:CBD.
[No authors listed]
Drugs R D. 2003;4(5):306-9. Review.
PMID: 12952500 [PubMed – indexed for MEDLINE]
Similar articles

 

124. Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy.
Gordon E, Devinsky O.
Epilepsia. 2001 Oct;42(10):1266-72. Review.
PMID: 11737161 [PubMed – indexed for MEDLINE] Free Article
Similar articles

 

125. Synthesis and pharmacological evaluation in mice of halogenated cannabidiol derivatives.
Usami N, Okuda T, Yoshida H, Kimura T, Watanabe K, Yoshimura H, Yamamoto I.
Chem Pharm Bull (Tokyo). 1999 Nov;47(11):1641-5.
PMID: 10605059 [PubMed – indexed for MEDLINE]
Similar articles

 

126. An investigation of the involvement of GABA in certain pharmacological effects of delta-9-tetrahydrocannabinol.
Pertwee RG, Browne SE, Ross TM, Stretton CD.
Pharmacol Biochem Behav. 1991 Nov;40(3):581-5.
PMID: 1666920 [PubMed – indexed for MEDLINE]
Similar articles

 

127. Structure-anticonvulsant activity relationships of cannabidiol analogs.
Martin AR, Consroe P, Kane VV, Shah V, Singh V, Lander N, Mechoulam R, Srebnik M.
NIDA Res Monogr. 1987;79:48-58.
PMID: 3125480 [PubMed – indexed for MEDLINE]
Similar articles

 

128. Anticonvulsant effect of cannabidiol.
Ames FR, Cridland S.
S Afr Med J. 1986 Jan 4;69(1):14. No abstract available.
PMID: 3941934 [PubMed – indexed for MEDLINE]
Similar articles

 

129. Changes in CNS sensitivity to cannabinoids with repeated treatment: tolerance and auxoesthesia.
Karler R, Calder LD, Turkanis SA.
NIDA Res Monogr. 1984;54:312-22. Review. No abstract available.
PMID: 6099877 [PubMed – indexed for MEDLINE]
Similar articles

 

130. Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice.
Consroe P, Benedito MA, Leite JR, Carlini EA, Mechoulam R.
Eur J Pharmacol. 1982 Sep 24;83(3-4):293-8.
PMID: 6129147 [PubMed – indexed for MEDLINE]
Similar articles

 

131. Effects of marihuana cannabinoids on seizure activity in cobalt-epileptic rats.
Colasanti BK, Lindamood C 3rd, Craig CR.
Pharmacol Biochem Behav. 1982 Apr;16(4):573-8.
PMID: 6280204 [PubMed – indexed for MEDLINE]
Similar articles

 

132. Central excitatory properties of delta 9-tetrahydrocannabinol and its metabolites in iron-induced epileptic rats.
Turkanis SA, Karler R.
Neuropharmacology. 1982 Jan;21(1):7-13.
PMID: 6278353 [PubMed – indexed for MEDLINE]
Similar articles

 

133. Antiepileptic potential of cannabidiol analogs.
Consroe P, Martin A, Singh V.
J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):428S-436S.
PMID: 7298873 [PubMed – indexed for MEDLINE]
Similar articles

 

134. Hypnotic and antiepileptic effects of cannabidiol.
Carlini EA, Cunha JM.
J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):417S-427S.
PMID: 7028792 [PubMed – indexed for MEDLINE]
Similar articles

 

135. The cannabinoids as potential antiepileptics.
Karler R, Turkanis SA.
J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):437S-448S.
PMID: 6975285 [PubMed – indexed for MEDLINE]
Similar articles

 

136. Electrophysiologic properties of the cannabinoids.
Turkanis SA, Karler R.
J Clin Pharmacol. 1981 Aug-Sep;21(8-9 Suppl):449S-463S.
PMID: 6271840 [PubMed – indexed for MEDLINE]
Similar articles

 

137. Rabbit behavioral model of marijuana psychoactivity in humans.
Consroe P, Fish BS.
Med Hypotheses. 1981 Aug;7(8):1079-90.
PMID: 6270517 [PubMed – indexed for MEDLINE]
Similar articles

 

138. Chronic administration of cannabidiol to healthy volunteers and epileptic patients.
Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, Sanvito WL, Lander N, Mechoulam R.
Pharmacology. 1980;21(3):175-85.
PMID: 7413719 [PubMed – indexed for MEDLINE]
Similar articles

 

139. An electrophysiological analysis of the anticonvulsant action of cannabidiol on limbic seizures in conscious rats.
Turkanis SA, Smiley KA, Borys HK, Olsen DM, Karler R.
Epilepsia. 1979 Aug;20(4):351-63.
PMID: 477630 [PubMed – indexed for MEDLINE]
Similar articles

 

140. The influence of cannabidiol and delta 9-tetrahydrocannabinol on cobalt epilepsy in rats.
Chiu P, Olsen DM, Borys HK, Karler R, Turkanis SA.
Epilepsia. 1979 Aug;20(4):365-75.
PMID: 113206 [PubMed – indexed for MEDLINE]
Similar articles

 

141. Toward drugs derived from cannabis.
Mechoulam R, Carlini EA.
Naturwissenschaften. 1978 Apr;65(4):174-9. Review.
PMID: 351429 [PubMed – indexed for MEDLINE]
Similar articles

 

142. Cannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats.
Consroe P, Wolkin A.
J Pharmacol Exp Ther. 1977 Apr;201(1):26-32.
PMID: 850145 [PubMed – indexed for MEDLINE]
Similar articles

 

143. Anticonvulsant drug antagonism of delta9tetrahydrocannabinol-induced seizures in rabbits.
Consroe P, Martin P, Eisenstein D.
Res Commun Chem Pathol Pharmacol. 1977 Jan;16(1):1-13.
PMID: 841172 [PubMed – indexed for MEDLINE]
Similar articles

 

144. Anticonvulsant activity of four oxygenated cannabidiol derivatives.
Carlini EA, Mechoulam R, Lander N.
Res Commun Chem Pathol Pharmacol. 1975 Sep;12(1):1-15.
PMID: 1188178 [PubMed – indexed for MEDLINE]
Similar articles

 

145. Interaction of delta9-tetrahydrocannabinol and cannabidiol with phenobarbitone in protecting mice from electrically induced convulsions.
Chesher GB, Jackson DM, Malor RM.
J Pharm Pharmacol. 1975 Aug;27(8):608-9. No abstract available.
PMID: 239178 [PubMed – indexed for MEDLINE]
Similar articles

 

146. The anticonvulsant activity of cannabinoids in seizure sensitive gerbils.
Cox B, ten Ham M, Loskota WJ, Lomax P.
Proc West Pharmacol Soc. 1975;18:154-7. No abstract available.
PMID: 1178662 [PubMed – indexed for MEDLINE]
Similar articles

 

147. Letter: Cannabidiol and electroencephalographic epileptic activity.
Perez-Reyes M, Wingfield M.
JAMA. 1974 Dec 23-30;230(12):1635. No abstract available.
PMID: 4612180 [PubMed – indexed for MEDLINE]
Similar articles

 

148. Letter: The effect of cannabidiol on maximal electroshock seizures in rats.
Izquierdo I, Tannhauser M.
J Pharm Pharmacol. 1973 Nov;25(11):916-7. No abstract available.
PMID: 4149660 [PubMed – indexed for MEDLINE]
Similar articles

 

149. Letter: Cannabidiol and Cannabis sativa extract protect mice and rats against convulsive agents.
Carlini EA, Leite JR, Tannhauser M, Berardi AC.
J Pharm Pharmacol. 1973 Aug;25(8):664-5. No abstract available.
PMID: 4148442 [PubMed – indexed for MEDLINE]
Similar articles

 

150. Effect of cannabidiol and of other cannabis sativa compounds on hippocampal seizure discharges.
Izquierdo I, Orsingher OA, Berardi AC.
Psychopharmacologia. 1973;28(1):95-102. No abstract available.
PMID: 4714680 [PubMed – indexed for MEDLINE]
Similar articles